Posted in | News

Songwon Forms Organotin Intermediates Strategic Supply Cooperation

Songwon is pleased to announce the cooperation with Nitto Kasei for the long term supply of Organotin Intermediates in Japan.

Following a recent agreement between Nitto Kasei and Sankyo Organic Chemicals of Japan, who have decided to stop the activities of their chemicals division to produce Organotin Stabilizers and Catalysts as of April 1st 2008, all production will be transferred to Nitto Kasei.

Songwon, who was previously appointed as the supply partner to Sankyo Organic Chemicals, has signed a long term agreement with Nitto Kasei to support their demand for intermediates, mainly Di-Alkyl Tin Oxide, for the production of tin based PVC stabilizers and catalysts.

Jongho Park, Chairman and CEO of Songwon Industrial Co., Ltd. commented: “This new agreement with Nitto Kasei reinforces our commitment to produce leading edge products and to maintain that position with key innovative developments; this is reflected in the long term nature of the agreement. We are also one of the few suppliers with backward integration into tin ingot which enables us to closely monitor quality and meet the demands of our customers”.

Ryuichi Katsumura, President and CEO of Nitto Kasei Co., Ltd. stated: “This is a great opportunity for us and we are keen to maintain the additional market share that we have taken on board from Sankyo and use that as a base to foster future growth. The quality of our products is reliant on key suppliers such as Songwon; we also needed to guarantee consistency and continuity to meet our growth agenda which is why we are pleased with the long term nature of this cooperation”.

Posted March 19th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.